No Data
No Data
Express News | XOMA Disclosed It Had Received An $8.1M Milestone Payment From Viracta Therapeutics, Inc., Related To Day One Biopharmaceuticals' Recent Sale Of Its Priority Review Voucher (Prv) For $108MTo An Undisclosed Buyer
Express News | XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of Its Priority Review Voucher
ImmunityBio, LadRx End Licensing Deal for Cancer Drug
LadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin License
Aldoxorubicin Returns to LadRx LadRx Corporation (OTCQB:LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, is pleased to announce
Peeling Back The Layers: Exploring XOMA Through Analyst Insights
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on XOMA (NASDAQ:XOMA) in the last three months.The table below offers a condensed view of their rec
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
EMERYVILLE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ:XOMA), the biotech royalty aggregator, announced today that members of its Executive Team will participate in the H.C. Wainwright 2nd Annual
No Data
QM137over1 : Friend, is there any good news from the Federal Reserve
TrytosaveabitOP QM137over1: Not yet! Supposed to release CPI at 8:30 AM est and Powell is supposed to speak about 2:30 PM est! Fingers crossed